Back to Results
First PageMeta Content
Amgen / Pharmacology / Thousand Oaks / California / Astellas Pharma / Osteoporosis / Monoclonal antibodies / Oncolytic virus / Romosozumab / Pharmaceutical drug / Health / Medicine / Anatomy


Microsoft PowerPoint - 130524_AAA_CEO_Deck_Joint__English_final.pptx
Add to Reading List

Document Date: 2013-05-29 06:19:52

Open Document

File Size: 1,66 MB

Share Result on Facebook

Company

Japan Amgen Astellas BioPharma KK Yoshihiko Hatanaka / Japan Strategic / UCB Hyperlipidemia / Astellas Strategic Alliance / Amgen / UCB / JJapan Yoshihiko Hatanaka / /

Country

Japan / United States / Brazil / China / /

Event

Security Buyback / Business Partnership / /

Facility

Five Pipeline / pipeline Hyperlipidemia AMG / /

IndustryTerm

existing and new products / legislation affecting pharmaceutical pricing / pharmaceuticals / biotechnology / healthcare cost containment / manufacturing / insurance plans / pharmaceutical / sales network / manufacturing problems / manufacturing capacity / /

MedicalCondition

lymphoblastic leukemia / lymphoma / mAb Small Molecule Antibody Oncolytic Vaccine Protein/Peptibody Osteoporosis / Anti-HGF mAb Gastric Cancer / Infectious Diseases / UCB Hyperlipidemia / /

Organization

New Alliance / Solid / U.S. government / Astellas Alliance / Astellas Strategic Alliance for the Japanese Market Long-term / U.S. Securities and Exchange Commission / /

Person

Astellas Pharma / Robert A. Bradway Ch / /

Position

Bradway Chairman and CEO / CEO / Chairman / President and CEO / forward / /

Product

Alli / /

SportsEvent

NHL / /

Technology

biotechnology / Transplantation / /

URL

www.amgen.com / /

SocialTag